Article info

Download PDFPDF
Economic evaluation of ASCOT-BPLA: antihypertensive treatment with an amlodipine-based regimen is cost effective compared with an atenolol-based regimen
  1. Dr P Lindgren, i3innovus, Vasagatan 38, 11120 Stockholm, Sweden; peter.lindgren{at}healtheconomics.se
View Full Text

Citation

Lindgren P, Buxton M, Kahan T, et al
Economic evaluation of ASCOT-BPLA: antihypertensive treatment with an amlodipine-based regimen is cost effective compared with an atenolol-based regimen

Publication history

  • Accepted August 7, 2007
  • First published October 4, 2007.
Online issue publication 
March 15, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.